Neon Therapeutics Stock Price, News & Analysis

NTGN NASDAQ

Company Description

Neon Therapeutics (NASDAQ: NTGN) is a publicly traded biotechnology company in the Health Technology sector.

NTGN stock has declined 50.5% over the past year.

This page provides a comprehensive overview of NTGN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-50.48%

Performance 1 year

$0.0

Market Cap

9.7M

Shares outstanding

Neon Therapeutics (NTGN) stock. Over the past 12 months, the stock has lost 50.5%.

Latest News

View All

No recent news available for NTGN.

SEC Filings

View All

No SEC filings available for NTGN.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

NTGN Company Profile & Sector Positioning

Neon Therapeutics (NTGN) operates in the Biotechnology industry within the broader Health Technology sector and is listed on the NASDAQ.